Publikasi

BASF introduces Floragenist floral active ingredients f...

BASF’s Personal Care business introduces Floragenist Rose and Floragenist Bloss...

BIRAC showcases biotech and medtech start-ups at Bharat...

BIRAC’s pavilion features start-ups working on medical devices, rehabilitation ...

Back to basics: Metal detection in pharmaceutical manuf...

Stuart Preston explains how metal detection supports contamination control, pro...

Scientists just created female clones of male mice

Scientists have deliberately turned male mouse embryos into females for the firs...

Moving Beyond Compliance: ABM’s Michael Ream on Buildin...

Michael Ream is a Director of Sales for Enterprise and Healthcare Solutions at A...

VIDEO: Clinical Trials Suggest GLP-1s May Improve ferti...

GLP-1s may improve testosterone levels and sperm quality in men with obesity rel...

Biopharma’s Drawdown Is a Chance to Build Biotech Back ...

American biotechnology hubs like Boston, Seattle, and San Diego are starting to ...

Human Biological Datacenter to Launch to Train World Mo...

Vivodyne confirms that it grows over 20 types of different human organ tissues, ...

Cortical Organoids Reveal Radial Glial Progenitor Linea...

Researchers reveal that radial glial progenitor lineage progression in cortical ...

In Vivo Protein Generation Using Nanoparticle Delivery:...

In this GEN webinar, our expert speaker, Tao (Tony) Li, PhD, will discuss nanopa...

Cancer-Fighting Abilities of NK Immune Cells May Be Dis...

Omega polyunsaturated fatty acids are recognized for their myriads of health ben...

New Research On Muscle Cramping

This week in the world of sports science, muscle cramping, running shoes, and ca...

Next 10 U.S. Biopharma Clusters

For the first time, GEN's Alex Philippidis examines the top regions and top stat...

Five Steps to Enable Self-Optimizing Process Purification

Self-optimization is the next evolutionary step for bioprocessing purification s...

Allogeneic CAR T Company Prepares to Widen Access to Pa...

An allogeneic CAR T-cell therapy company is planning a pivotal Phase III randomi...